Saizen (Serono SA) en es it fr

Saizen (Serono SA) Brand names, Saizen (Serono SA) Analogs

Saizen (Serono SA) Brand Names Mixture

  • No information avaliable

Saizen (Serono SA) Chemical_Formula


Saizen (Serono SA) RX_link

Saizen (Serono SA) fda sheet

Saizen (Serono SA) msds (material safety sheet)

Saizen (Serono SA) Synthesis Reference

No information avaliable

Saizen (Serono SA) Molecular Weight


Saizen (Serono SA) Melting Point

76 oC at pH 3.5 (Gomez-Orellana, I. et al., Protein Sci. 7:1352-1358 (1998).

Saizen (Serono SA) H2O Solubility

No information avaliable

Saizen (Serono SA) State


Saizen (Serono SA) LogP


Saizen (Serono SA) Dosage Forms

Solution (Subcutaneous Injection); Powder for solution

Saizen (Serono SA) Indication

For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss

Saizen (Serono SA) Pharmacology

Used in the treatment of dwarfism and growth failure, growth hormone (hGH) stimulates skeletal growth in pediatric patients with growth failure due to a lack of adequate secretion of endogenous GH. Skeletal growth is accomplished at the epiphyseal plates at the ends of a growing bone. Growth and metabolism of epiphyseal plate cells are directly stimulated by GH and one of its mediators, IGF-I (insulin-like growth factor).

Saizen (Serono SA) Absorption

No information avaliable

Saizen (Serono SA) side effects and Toxicity

No information avaliable

Saizen (Serono SA) Patient Information


Saizen (Serono SA) Organisms Affected

Humans and other mammals